These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 13871204)

  • 1. The hemostatic effect of normal platelets in hemophilia and factor V deficiency. The importance of clotting factors adsorbed on platelets for normal hemostasis.
    BORCHGREVINK CF; OWREN PA
    Acta Med Scand; 1961 Sep; 170():375-83. PubMed ID: 13871204
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital combined deficiency of factor V and factor 8. A case report and the effect of transfusion of normal plasma and hemophilic blood.
    Saito H; Shioya M; Koie K; Kamiya T; Katsumi O
    Thromb Diath Haemorrh; 1969 Nov; 22(2):316-25. PubMed ID: 5380951
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy reviews: clinical use of hemostatic agents.
    Lowe GD; Lawson DH
    Am J Hosp Pharm; 1978 Apr; 35(4):414-22. PubMed ID: 306196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE DIAGNOSIS AND MANAGEMENT OF BLEEDING DISORDERS.
    HOAK JC; CONNOR WE; WARNER ED
    J Iowa Med Soc; 1964 Jul; 54():331-41. PubMed ID: 14157038
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on platelets. II. The effect of transfusion of platelet-rich polycythemic blood on the platelets and hemostatic function in "idiopathic" and "secondary" thrombocytopenic purpura.
    STEFANINI M; CHATTERJEA JB; DAMESHEK W; ZANNOS L; SANTIAGO EP
    Blood; 1952 Jan; 7(1):53-76. PubMed ID: 14886410
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of coagulation factor deficiencies.
    Temperley IJ
    J Ir Med Assoc; 1973 Jan; 66(2):42-5. PubMed ID: 4688930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient with factor V deficiency (parahemophilia) diagnosed and treated as hemophilia A].
    Lisichkov T; Arnaudov G
    Vutr Boles; 1984; 23(6):109-11. PubMed ID: 6531864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice.
    Baumgartner CK; Mattson JG; Weiler H; Shi Q; Montgomery RR
    J Thromb Haemost; 2017 Jan; 15(1):98-109. PubMed ID: 27496751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. THE RELATION OF COAGULATION FACTOR DEFECTS TO SURGICAL BLOOD LOSS.
    OLWIN JH; KOPPEL JL
    Ann N Y Acad Sci; 1964 Jul; 115():43-55. PubMed ID: 14192853
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemophilia: the blood bank's concern?].
    Smit Sibinga CT
    Ned Tijdschr Geneeskd; 1978 Sep; 122(37):1359-62. PubMed ID: 692762
    [No Abstract]   [Full Text] [Related]  

  • 12. Disappearance rates of coagulation factors: transfusion studies in factor-deficient patients.
    Bowie EJ; Thompson JH; Didisheim P; Owen CA
    Transfusion; 1967; 7(3):174-84. PubMed ID: 6025693
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombokinase formation and the reaction of thrombocyte factor 1 in hypoproacelerinemia (parahemophilia); preliminary report].
    DEUTSCH E
    Wien Z Inn Med; 1955 Aug; 36(8):355-7. PubMed ID: 13282274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Modern trends in the therapy of congenital and acquired coagulopathies].
    Girolami A
    Clin Ter; 1968 Jun; 45(5):469-93. PubMed ID: 4901167
    [No Abstract]   [Full Text] [Related]  

  • 15. Clotting defect in hemophilia; deficiency in a plasma factor required for platelet utilization.
    BRINKHOUS KM
    Proc Soc Exp Biol Med; 1947 Oct; 66(1):117-20. PubMed ID: 20270694
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemostatic effects of peanut seed husks].
    CEPELAK V
    Z Gesamte Inn Med; 1961 Dec; 16():1100. PubMed ID: 13877675
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemophilia].
    Epifanov NS
    Feldsher Akush; 1986 Sep; 51(9):29-32. PubMed ID: 3643124
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and monitoring of bypassing agent therapy.
    Hoffman M; Dargaud Y
    J Thromb Haemost; 2012 Aug; 10(8):1478-85. PubMed ID: 22632160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemostatic effect of preserved blood in hemophilia and Werlhof's disease].
    Riabyĭ PA
    Vrach Delo; 1972 Apr; 4():47-9. PubMed ID: 5065572
    [No Abstract]   [Full Text] [Related]  

  • 20. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors.
    Monahan PE
    Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.